The Role of lncRNAs in the TNF Pathway in Patients with COVID-19: A Narrative Review
Open Access
- 23 August 2026
- journal article
- Published by Brieflands in International Journal of Infection
- Vol. 13 (1) , e174036
Abstract
Context: SARS-CoV-2 infection can trigger a severe inflammatory response and, in critical cases, cytokine storm syndrome. Tumor necrosis factor-alpha (TNF-α) is a key cytokine involved in this process. Long non-coding RNAs (lncRNAs), which regulate gene expression and immune responses, may modulate TNF-α-related inflammatory pathways in COVID-19. Evidence Acquisition: This review examined the role of lncRNAs involved in the TNF pathway in patients with COVID-19, focusing on their regulatory mechanisms, associations with disease severity, and potential clinical applications. Results: Several lncRNAs, including NEAT1 (Nuclear Enriched Abundant Transcript 1), MALAT1 (Metastasis-Associated Lung Adenocarcinoma Transcript 1), THRIL (TNF-alpha and hnRNPL Related Immunoregulatory LncRNA), GAS5 (Growth Arrest-Specific 5), TUG1 (Taurine Up-Regulated 1), and HULC (Highly Upregulated in Liver Cancer), were found to modulate TNF-α and other inflammatory cytokines via mechanisms such as microRNA sponging, epigenetic regulation, and transcriptional control. Evidence from immune interventions, including BCG vaccination and immunonutrition, as well as bioinformatics-based network analyses, further supports the involvement of lncRNAs in the regulation of the TNF pathway. Altered expression of these lncRNAs was associated with COVID-19 severity, prognosis, and treatment response. Conclusions: LncRNAs involved in the TNF signaling pathway may contribute to the inflammatory response and clinical severity of COVID-19. Accordingly, they may serve as potential diagnostic and prognostic biomarkers and as promising therapeutic targets for the management of COVID-19.Keywords
This publication has 30 references indexed in Scilit:
- A human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defenseProceedings of the National Academy of Sciences, 2026
- The coordinated regulation of CASC2/miR-200c/miR-20b and SIRT1/ACE-2/IL-6 Axes in COVID-19 pneumonia: Novel molecular diagnostic and therapeutic insightsArchives of Biochemistry and Biophysics, 2026
- NEAT1 drives SARS-CoV-2 N protein–induced inflammation, metabolic reprogramming, and mitochondria–ER stress crosstalkScientific Reports, 2026
- Response to comments for: Dysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTBTuberculosis, 2026
- Dysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTBTuberculosis, 2025
- Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targetsSignal Transduction and Targeted Therapy, 2023
- Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severityVirus Research, 2023
- Expression pattern of long non‐coding RNAs MALAT1 and MEG3 in COVID‐19 patientsThe Journal of Gene Medicine, 2023
- The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 diseaseThe Brazilian Journal of Infectious Diseases, 2022
- A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral bloodScientific Reports, 2021